Dyne Therapeutics Stock Down 30% in a Year — So Why Did One Investor Add Nearly 1 Million Shares?

California-based Palo Alto Investors added 997,698 shares of Dyne Therapeutics (NASDAQ:DYN) in the third quarter, contributing to a position increase of about $13.5 million, per a November 14 SEC filing.Palo Alto Investors LP disclosed in its SEC filing dated November 14 that it increased its holding in Dyne Therapeutics (NASDAQ:DYN) by 997,698 shares during the third quarter. The post-trade position totals nearly 1.3 million shares with a quarter-end value of $16 million, reflecting both additional purchases and the period’s price changes.The buy lifted Dyne Therapeutics to 3% of 13F AUM as of September 30.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool